collection
MENU ▼
Read by QxMD icon Read
search

Liver mets

shared collection
34 papers 25 to 100 followers
https://www.readbyqxmd.com/read/29664996/prognostic-impact-of-perihepatic-lymph-node-metastases-in-patients-with-resectable-colorectal-liver-metastases
#1
M Okuno, C Goumard, T Mizuno, S Kopetz, K Omichi, C-W D Tzeng, Y S Chun, J E Lee, J-N Vauthey, C Conrad
BACKGROUND: Although perihepatic lymph node metastases (PLNMs) are known to be a poor prognosticator for patients with colorectal liver metastases (CRLMs), optimal management remains unclear. This study aimed to determine the risk factors for PLNMs, and the survival impact of their number and location in patients with resectable CRLMs. METHODS: Data on patients with CRLM who underwent hepatectomy during 2003-2014 were analysed retrospectively. Recurrence-free (RFS) and overall (OS) survival were calculated according to presence, number and location of PLNMs...
April 17, 2018: British Journal of Surgery
https://www.readbyqxmd.com/read/29459018/prognostic-significance-of-18-f-fdg-pet-ct-in-patients-with-colorectal-cancer-liver-metastases-after-hepatectomy
#2
Jae-Ryong Shim, Seung Duk Lee, Sung-Sik Han, Sang Jae Lee, Dong Eun Lee, Seok-Ki Kim, Seong Hoon Kim, Sang Jae Park, Jae-Hwan Oh
INTRODUCTION: Colorectal cancer liver metastasis (CRLM) can be cured with surgery. To improve survival, optimal selection of CRLM patients should be done cautiously, which may be facilitated by preoperative [F-18] fluorodeoxyglucose positron emission tomography/computed tomography (18 F-FDG PET/CT). METHODS: A total of 245 patients with CRLM between February 2007 and January 2015 were retrospectively studied. All clinical variables, pathological data, and various PET/CT parameters were correlated with disease-free survival (DFS) and overall survival (OS)...
February 6, 2018: European Journal of Surgical Oncology
https://www.readbyqxmd.com/read/29532908/survival-following-liver-transplantation-for-liver-only-colorectal-metastases-compared-with-hepatocellular-carcinoma
#3
S Dueland, A Foss, J M Solheim, M Hagness, P-D Line
BACKGROUND: Liver transplantation is considered the standard of care for patients with hepatocellular carcinoma (HCC) within the Milan criteria. Liver transplantation in patients with unresectable colorectal cancer with liver-only disease has been shown to be associated with a 5-year overall survival rate of 56 per cent, compared with 9 per cent in patients receiving standard palliative chemotherapy. The aim of the present study was to compare disease-free (DFS) and overall (OS) survival after liver transplantation in patients with HCC and those with colorectal metastases...
March 13, 2018: British Journal of Surgery
https://www.readbyqxmd.com/read/28930294/surgery-kras-mutations-and-hepatic-recurrence-after-treatment-of-colorectal-liver-metastases
#4
Kristoffer Watten Brudvik, Jean-Nicolas Vauthey
No abstract text is available yet for this article.
November 2017: Nature Reviews. Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28807246/hepatic-intra-arterial-injection-of-irinotecan-drug-eluting-beads-debiri-for-patients-with-unresectable-colorectal-liver-metastases-a%C3%A2-systematic-review
#5
REVIEW
Olaguoke Akinwande, Meaghan Dendy, Johannes M Ludwig, Hyun S Kim
PURPOSE: To systematically review the safety and efficacy of transarterial drug-eluting beads, irinotecan (DEBIRI) for the treatment of pretreated patients with unresectable colorectal liver metastases (CRLM). METHODS: A systematic search of the current literature was conducted to extract publications reporting on the use of DEBIRI for CRLM. Data on the safety and efficacy was extracted and tabulated. Weighted average values (WAV) were calculated for each variable to provide a single value representing the pooled safety and efficacy data...
September 2017: Surgical Oncology
https://www.readbyqxmd.com/read/28417185/combined-preoperative-portal-and-hepatic-vein-embolization-biembolization-to-improve-liver-regeneration-before-major-liver-resection-a-preliminary-report
#6
Bertrand Le Roy, Antoine Perrey, Mikael Fontarensky, Johan Gagnière, Armand Abergel, Bruno Pereira, Celine Lambert, Louis Boyer, Denis Pezet, Pascal Chabrot, Emmanuel Buc
BACKGROUND: Insufficient volume of the future liver remnant (FLR) is a major cause of non-resectable disease in patients presenting with primary or metastatic liver tumours. The objective of this study was to evaluate the safety and efficacy of the combined preoperative portal and hepatic vein embolization (biembolization) before extended right liver resections. METHODS: This retrospective study was performed in a tertiary centre between 2014 and 2015. Combined right portal and hepatic vein embolization (biembolization) was proposed, as an alternative to ALPPS procedure, for all patients with primary or metastatic liver tumour, before right extended hepatectomy...
July 2017: World Journal of Surgery
https://www.readbyqxmd.com/read/27807727/positron-emission-tomography-computed-tomography-for-patients-with-recurrent-colorectal-liver-metastases-impact-on-restaging-and-treatment-planning
#7
Luca Viganò, Egesta Lopci, Guido Costa, Marcello Rodari, Dario Poretti, Vittorio Pedicini, Luigi Solbiati, Arturo Chiti, Guido Torzilli
BACKGROUND: The impact of fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) for patients with colorectal liver metastases (CLM) still is debated. Its relevance could be enhanced in the case of recurrent disease. The current study aimed to elucidate the role of PET-CT in restaging and treatment planning for recurrent CLM. METHODS: A series of 352 consecutive patients undergoing their first liver resection for CLM between 2005 and 2014 was reviewed...
April 2017: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/28187043/difficulty-of-laparoscopic-liver-resection-proposal-for-a-new-classification
#8
Yoshikuni Kawaguchi, David Fuks, Norihiro Kokudo, Brice Gayet
OBJECTIVE: We propose an objective and practical classification system to predict difficulty of different laparoscopic liver resections (LLRs). BACKGROUND: Surgical difficulty is highly subjective and is not influenced only by surgical factors. Consequently, few series have described the degree of difficulty of LLR or attempted to objectively assess the surgical difficulty. METHODS: From a prospectively maintained database between 1995 and 2015, patients undergoing LLR without simultaneous procedures were selected, and LLR procedures were divided into 3 groups according to scores based on operative time (< or ≥190 minutes), blood loss (< or ≥100 mL), and conversion rate (< or ≥4...
January 2018: Annals of Surgery
https://www.readbyqxmd.com/read/28109616/hammer-versus-swiss-army-knife-developing-a-strategy-for-the-management-of-bilobar-colorectal-liver-metastases
#9
REVIEW
Jordan M Cloyd, Thomas A Aloia
For patients with bilobar colorectal liver metastases, the recent increase in surgical approaches has resulted in more opportunities to extend the benefits of surgery to patients who were previously deemed unresectable. Surgical options now include anatomic hepatectomy, 1-stage parenchymal sparing hepatectomy, traditional 2-stage hepatectomy with or without portal vein embolization, associated liver partition and portal vein ligation for staged hepatectomy, local ablative techniques, and hepatic arterial infusion therapy...
July 2017: Surgery
https://www.readbyqxmd.com/read/28146608/neuroendocrine-liver-metastasis-the-chance-to-be-cured-after-liver-surgery
#10
Fabio Bagante, Gaya Spolverato, Katiuscha Merath, Lauren McLendon Postlewait, George A Poultsides, Matthew G Mullen, Todd W Bauer, Ryan C Fields, Jorge Lamelas, Hugo P Marques, Luca Aldrighetti, Thuy Tran, Shishir K Maithel, Timothy M Pawlik
BACKGROUND AND OBJECTIVE: Neuroendocrine liver metastasis tumors (NELM) are a heterogeneous group of neoplasms with varied histologic features and a wide range of clinical behaviors. We aimed to identify the fraction of patients cured after liver surgery for NELM. METHODS: Cure fraction models were used to analyze 376 patients who underwent hepatectomy with curative intent for NELM. RESULTS: The median and 5-year disease-free survival (DFS) were 4...
May 2017: Journal of Surgical Oncology
https://www.readbyqxmd.com/read/28002060/embryonic-origin-of-primary-colon-cancer-predicts-pathologic-response-and-survival-in-patients-undergoing-resection-for-colon-cancer-liver-metastases
#11
Suguru Yamashita, Kristoffer Watten Brudvik, Scott E Kopetz, Dipen Maru, Callisia N Clarke, Guillaume Passot, Claudius Conrad, Yun Shin Chun, Thomas A Aloia, Jean-Nicolas Vauthey
BACKGROUND: The aim of this study was to determine the prognostic value of embryonic origin in patients undergoing resection after chemotherapy for colon cancer liver metastases (CCLM). METHODS: We identified 725 patients with primary colon cancer and known RAS mutation status who underwent hepatic resection after preoperative chemotherapy for CCLM (1990 to 2015). Survival after resection of CCLM from midgut origin (n = 238) and hindgut origin (n = 487) was analyzed...
December 19, 2016: Annals of Surgery
https://www.readbyqxmd.com/read/27380959/esmo-consensus-guidelines-for-the-management-of-patients-with-metastatic-colorectal-cancer
#12
E Van Cutsem, A Cervantes, R Adam, A Sobrero, J H Van Krieken, D Aderka, E Aranda Aguilar, A Bardelli, A Benson, G Bodoky, F Ciardiello, A D'Hoore, E Diaz-Rubio, J-Y Douillard, M Ducreux, A Falcone, A Grothey, T Gruenberger, K Haustermans, V Heinemann, P Hoff, C-H Köhne, R Labianca, P Laurent-Puig, B Ma, T Maughan, K Muro, N Normanno, P Österlund, W J G Oyen, D Papamichael, G Pentheroudakis, P Pfeiffer, T J Price, C Punt, J Ricke, A Roth, R Salazar, W Scheithauer, H J Schmoll, J Tabernero, J Taïeb, S Tejpar, H Wasan, T Yoshino, A Zaanan, D Arnold
Colorectal cancer (CRC) is one of the most common malignancies in Western countries. Over the last 20 years, and the last decade in particular, the clinical outcome for patients with metastatic CRC (mCRC) has improved greatly due not only to an increase in the number of patients being referred for and undergoing surgical resection of their localised metastatic disease but also to a more strategic approach to the delivery of systemic therapy and an expansion in the use of ablative techniques. This reflects the increase in the number of patients that are being managed within a multidisciplinary team environment and specialist cancer centres, and the emergence over the same time period not only of improved imaging techniques but also prognostic and predictive molecular markers...
August 2016: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://www.readbyqxmd.com/read/27395013/functional-imaging-in-liver-tumours
#13
REVIEW
Maxime Ronot, Ashley Kieran Clift, Valérie Vilgrain, Andrea Frilling
Functional imaging encompasses techniques capable of assessing physiological parameters of tissues, and offers useful clinical information in addition to that obtained from morphological imaging. Such techniques may include magnetic resonance imaging with diffusion-weighted sequences or hepatobiliary contrast agents, perfusion imaging, or molecular imaging with radiolabelled tracers. The liver is of major importance in oncological practice; not only is hepatocellular carcinoma one of the malignancies with steadily rising incidence worldwide, but hepatic metastases are regularly observed with a range of solid neoplasms...
November 2016: Journal of Hepatology
https://www.readbyqxmd.com/read/27311006/an-updated-systematic-review-of-the-evolution-of-alpps-and-evaluation-of-its-advantages-and-disadvantages-in-accordance-with-current-evidence
#14
REVIEW
Yu-Long Cai, Pei-Pei Song, Wei Tang, Nan-Sheng Cheng
The main obstacle to achieving an R0 resection after a major hepatectomy is inability to preserve an adequate future liver remnant (FLR) to avoid postoperative liver failure (PLF). Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is a novel technique for resecting tumors that were previously considered unresectable, and this technique results in a vast increase in the volume of the FLR in a short period of time. However, this technique continues to provoke heated debate because of its high mortality and morbidity...
June 2016: Medicine (Baltimore)
https://www.readbyqxmd.com/read/27306949/factors-influencing-recurrence-following-initial-hepatectomy-for-colorectal-liver-metastases
#15
MULTICENTER STUDY
J Hallet, A Sa Cunha, R Adam, D Goéré, P Bachellier, D Azoulay, A Ayav, E Grégoire, F Navarro, P Pessaux
BACKGROUND: Data on recurrence patterns following hepatectomy for colorectal liver metastases (CRLMs) and their impact on long-term outcomes are limited in the setting of modern multimodal management. This study sought to characterize the patterns of, factors associated with, and survival impact of recurrence following initial hepatectomy for CRLMs. METHODS: A retrospective cohort study of patients undergoing initial hepatectomy for CRLMs at 39 institutions (2006-2013) was conducted...
September 2016: British Journal of Surgery
https://www.readbyqxmd.com/read/26948499/the-laparoscopic-glissonian-approach-is-safe-and-efficient-when-compared-with-standard-laparoscopic-liver-resection-results-of-an-observational-study-over-7-years
#16
COMPARATIVE STUDY
Marcel Autran C Machado, Rodrigo C Surjan, Tiago Basseres, Erik Schadde, Frederico P Costa, Fábio F Makdissi
OBJECTIVE: This study compares the Glissonian approach with the standard approach to laparoscopic liver resection for safety and efficacy. BACKGROUND: The standard laparoscopic approach to anatomic liver resection is the dissection of the elements of the Glissonian pedicle below the hilar plate. In contrast, the Glissonian approach identifies the intrahepatic pedicles by tentative clamping. Concerns have been raised about the safety of the Glissonian approach in laparoscopic liver surgery...
September 2016: Surgery
https://www.readbyqxmd.com/read/26641255/second-and-third-laparoscopic-liver-resection-for-patients-with-recurrent-colorectal-liver-metastases
#17
Takeo Nomi, David Fuks, Satoshi Ogiso, Yoshiyuki Nakajima, Christophe Louvet, Brice Gayet
No abstract text is available yet for this article.
May 2016: Annals of Surgery
https://www.readbyqxmd.com/read/26631387/decision-making-around-optimal-management-of-liver-limited-metastatic-colorectal-cancer
#18
EDITORIAL
Robert P Jones, Graeme J Poston
No abstract text is available yet for this article.
February 2016: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/26496211/a-multi-institutional-analysis-of-429-patients-undergoing-major-hepatectomy-for-colorectal-cancer-liver-metastases-the-impact-of-concomitant-bile-duct-resection-on-survival
#19
MULTICENTER STUDY
Lauren M Postlewait, Malcolm H Squires, David A Kooby, Sharon M Weber, Charles R Scoggins, Kenneth Cardona, Clifford S Cho, Robert C G Martin, Emily R Winslow, Shishir K Maithel
BACKGROUND: Data are lacking on long-term outcomes of patients undergoing major hepatectomy requiring bile duct resection (BDR) for the treatment of colorectal cancer liver metastases. METHODS: Patients who underwent major hepatectomy (≥3 segments) for metastatic colorectal cancer from 2000-2010 at three US academic institutions were included. The primary outcome was disease-specific survival (DSS). RESULTS: Of 429 patients, nine (2.1%) underwent BDR, which was associated with pre-operative portal vein embolization (25...
October 2015: Journal of Surgical Oncology
https://www.readbyqxmd.com/read/26133575/systematic-review-and-meta-analysis-of-hepatic-arterial-infusion-chemotherapy-as-bridging-therapy-for-colorectal-liver-metastases
#20
REVIEW
Daniel L Chan, Nayef A Alzahrani, David L Morris, Terence C Chua
BACKGROUND: Hepatic arterial infusion chemotherapy (HAIC) has been shown to be beneficial in the management of unresectable colorectal liver metastases (CRLM). This systematic review evaluates the potential role of HAIC as a neoadjuvant downstaging therapy, prior to hepatic resection with curative intent for initially unresectable CRLM. METHODS: A literature search was conducted using Pubmed, EMBASE and Medline databases from January 2000 to November 2013. Studies adopting HAIC as a neoadjuvant bridging therapy for hepatic resection for CRLM were included...
September 2015: Surgical Oncology
label_collection
label_collection
4512
1
2
2015-07-20 17:40:07
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"